Providence Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Providence Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.4M	Buy	85,900 +6,900	+9%	+$605K	1.12%	35
2026 Q1	$7.14M	Buy	79,000 +4,200	+6%	+$385K	1.17%	33
2025 Q4	$6.73M	Buy	+74,800	New	+$7.09M	1.13%	31
2025 Q3	–	Sell	-65,100	Closed	-$5.94M	–	249
2025 Q2	$5.94M	Buy	65,100 +8,700	+15%	+$841K	1.09%	41
2025 Q1	$6.38M	Buy	56,400 +800	+1%	+$85.6K	1.33%	22
2024 Q4	$5.87M	Buy	55,600 +2,800	+5%	+$300K	1.19%	37
2024 Q3	$5.7M	Buy	52,800 +4,191	+9%	+$457K	1.13%	42
2024 Q2	$5.28M	Buy	48,609 +48,600	+540,000%	+$5.73M	1.15%	40
2024 Q1	$1.19K	Buy	+9	New	+$1.12K	﹤0.01%	311
2019 Q2	–	Sell	-41	Closed	-$5K	–	295
2019 Q1	$5K	Hold	41	–	–	﹤0.01%	218
2018 Q4	$4K	Hold	41	–	–	﹤0.01%	229
2018 Q3	$5K	Hold	41	–	–	﹤0.01%	234
2018 Q2	$4K	Hold	41	–	–	﹤0.01%	235
2018 Q1	$4K	Hold	41	–	–	﹤0.01%	234
2017 Q4	$5K	Buy	+41	New	+$4.64K	﹤0.01%	268

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Providence Capital Advisors's ZBH Position: Q2 2026 in Review

Providence Capital Advisors increased its Zimmer Biomet (ZBH) stake by 8.7% in Q2 2026, buying an estimated $605K and bringing the position to 85,900 shares worth $7.4M. The position accounts for 1.12% of the portfolio, ranked #35.

Providence Capital Advisors first reported a position in ZBH in Q4 2017 and has held it in 15 quarters since. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Providence Capital Advisors held 85,900 shares of Zimmer Biomet worth $7.4M as of Q2 2026.
Providence Capital Advisors bought 6,900 Zimmer Biomet shares in Q2 2026, an estimated $605K.
Zimmer Biomet made up 1.12% of Providence Capital Advisors's portfolio in Q2 2026, its #35 holding.
Providence Capital Advisors first reported a position in Zimmer Biomet in Q4 2017 and has held it in 15 quarters since.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Providence Capital Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.